Thyrocare Technologies Complete Financial Statements
12 Years of Data
2026 - 2015
In FY2026, Thyrocare Technologies (THYROCARE) reported revenue ₹229 Cr, net profit ₹49 Cr and EPS ₹2.99, with a net profit margin of 21.4% and ROE of 8.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see THYROCARE screener.
Complete Financial Data Export
Profitability Ratios
Net Profit Margin
21.40%
2026 data
EBITDA Margin
34.93%
2026 data
Operating Margin
34.00%
2026 data
Return on Assets
6.56%
2026 data
Return on Equity
8.36%
2026 data
Balance Sheet Ratios
Current Ratio
7.29
2026 data
Equity Ratio
78.45%
2026 data
Asset Turnover
0.31
2026 data
THYROCARE Revenue, Net Profit & EBITDA — Year-on-Year Growth
THYROCARE YoY (Mar 2025 vs Mar 2026) — revenue +19.3%, net profit +122.7%, EBITDA +29.0%, expenses +14.6%. Review THYROCARE earnings valuation to evaluate earnings-based valuation against sector peers.
Revenue Growth
+19.3%
Year-over-Year
Net Profit Growth
+122.7%
Year-over-Year
EBITDA Growth
+29.0%
Year-over-Year
Expense Growth
+14.6%
Year-over-Year
Assets Growth
+7.8%
Year-over-Year
Equity Growth
+7.1%
Year-over-Year
Operating Cash Flow Growth
+13.7%
Year-over-Year
Investing Cash Flow Growth
+41.8%
Year-over-Year
Financing Cash Flow Growth
-52.9%
Year-over-Year
THYROCARE Income Statement — Revenue, EBITDA & Net Profit
Thyrocare Technologies revenue ₹229 Cr, EBITDA ₹80 Cr, net profit ₹49 Cr, EPS ₹2.99 (2026) — net profit margin 21.4%. Explore Thyrocare Technologies intrinsic price to estimate fundamental worth using multiple valuation models.
Periods
₹ Crores
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 229 | 220 | 192 | 198 | 201 | 180 | 158 | 161 | 170 | 151 | 140 | 136 | 138 | 137 | 133 | 129 | 131 | 191 | 151 | 175 | 119 | 158 | 104 | 58 | 141 | 119 | 108 | 112 | 107 | 107 | 108 | 99 | 100 | 92 | 89 | 93 | 88 | 81 | 67 | 72 | 74 | 63 | 56 | 55 |
| Expenses | 149 | 145 | 130 | 135 | 144 | 129 | 121 | 115 | 124 | 111 | 111 | 100 | 103 | 103 | 93 | 92 | 100 | 87 | 95 | 94 | 81 | 91 | 77 | 48 | 89 | 64 | 71 | 64 | 62 | 61 | 60 | 56 | 61 | 53 | 60 | 53 | 49 | 64 | 41 | 42 | 51 | 36 | 37 | 35 |
| EBITDA | 80 | 75 | 62 | 63 | 57 | 51 | 37 | 46 | 46 | 40 | 29 | 36 | 35 | 33 | 40 | 37 | 31 | 104 | 55 | 81 | 38 | 67 | 26 | 9 | 52 | 55 | 37 | 48 | 45 | 46 | 48 | 43 | 39 | 39 | 30 | 39 | 39 | 17 | 27 | 30 | 23 | 26 | 20 | 20 |
| Operating Profit Margin % | 34.00% | 33.00% | 30.00% | 30.00% | 26.00% | 27.00% | 22.00% | 27.00% | 25.00% | 25.00% | 18.00% | 26.00% | 23.00% | 23.00% | 29.00% | 28.00% | 22.00% | 51.00% | 35.00% | 43.00% | 31.00% | 40.00% | 24.00% | 15.00% | 36.00% | 45.00% | 33.00% | 42.00% | 41.00% | 41.00% | 39.00% | 42.00% | 37.00% | 40.00% | 32.00% | 39.00% | 42.00% | 18.00% | 38.00% | 39.00% | 28.00% | 39.00% | 34.00% | 36.00% |
| Depreciation | 14 | 12 | 14 | 11 | 22 | 13 | 13 | 11 | 17 | 11 | 11 | 10 | 14 | 9 | 10 | 9 | 10 | 8 | 8 | 7 | 9 | 8 | 9 | 7 | 8 | 8 | 7 | 7 | 8 | 7 | 6 | 6 | 7 | 5 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 5 |
| Interest | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 64 | 63 | 47 | 51 | 35 | 37 | 23 | 34 | 28 | 28 | 17 | 25 | 20 | 24 | 30 | 28 | 20 | 95 | 48 | 74 | 29 | 59 | 18 | 2 | 44 | 46 | 29 | 40 | 37 | 39 | 42 | 38 | 32 | 34 | 25 | 35 | 34 | 13 | 22 | 26 | 19 | 25 | 17 | 19 |
| Tax | 16 | 15 | 26 | 12 | 7 | 10 | 6 | 10 | 9 | 8 | 5 | 8 | 5 | 8 | 9 | 6 | 5 | 18 | 10 | 18 | 7 | 16 | 19 | 2 | 12 | 11 | 13 | 13 | 9 | 14 | 17 | 14 | 12 | 10 | 9 | 13 | 12 | 11 | 8 | 9 | 9 | 9 | 6 | 8 |
| Net Profit | 49 | 48 | 22 | 38 | 28 | 26 | 17 | 24 | 19 | 20 | 13 | 17 | 15 | 15 | 21 | 22 | 15 | 78 | 38 | 56 | 22 | 43 | -2 | 0 | 32 | 35 | 16 | 28 | 28 | 25 | 25 | 23 | 20 | 25 | 15 | 22 | 22 | 1 | 14 | 17 | 9 | 16 | 11 | 11 |
| Earnings Per Share (₹) | 2.99 | 9.05 | 4.17 | 7.35 | 1.82 | 4.99 | 3.54 | 4.52 | 3.58 | 3.84 | 2.36 | 3.26 | 2.78 | 3.80 | 4.04 | 4.11 | 2.78 | 14.70 | 7.14 | 10.51 | 4.05 | 8.15 | -0.30 | 0.04 | 6.13 | 6.73 | 3.09 | 5.20 | 5.21 | 4.70 | 4.68 | 4.35 | 3.81 | 4.59 | 2.90 | 4.10 | 4.03 | 0.22 | 2.71 | 3.18 | 1.71 | 3.28 | 2.33 | 2.13 |
THYROCARE Balance Sheet — Assets, Liabilities & Shareholders' Equity
THYROCARE total assets ₹747 Cr, total equity ₹586 Cr, total liabilities ₹ Cr (2026) — ROE 8.4%.
Years
Annual Data
₹ Crores
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 747 | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 | 410 | 329 |
| Current Assets | 372 | 338 | 279 | 273 | 270 | 240 | 152 | 136 | 142 | 150 | 134 | 111 |
| Fixed Assets | 212 | 297 | 306 | 294 | 285 | 253 | 269 | 294 | 299 | 259 | 259 | 196 |
| Capital Work in Progress | 3 | 14 | 3 | 2 | 3 | 8 | 5 | 2 | 0 | 17 | 1 | 6 |
| Investments | 49 | 162 | 162 | 144 | 146 | 126 | 90 | 95 | 120 | 104 | 92 | 84 |
| Other Assets | 0 | 220 | 173 | 193 | 174 | 159 | 107 | 84 | 60 | 58 | 58 | 43 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 51 | 24 | 26 | 20 | 17 | 23 | 23 | 19 | 15 | 12 | 13 | 10 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 586 | 547 | 528 | 535 | 527 | 427 | 367 | 435 | 443 | 408 | 366 | 312 |
| Share Capital | 159 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 54 | 54 | 54 | 51 |
| Reserves & Surplus | 426 | 439 | 440 | 463 | 474 | 374 | 314 | 382 | 390 | 354 | 312 | 226 |
THYROCARE Cash Flow Statement — Operating, Investing & Financing
Thyrocare Technologies operating cash flow ₹191 Cr, investing ₹-53 Cr, financing ₹-130 Cr, net cash flow ₹8 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 191 | 168 | 129 | 113 | 115 | 168 | 100 | 107 | 90 | 68 | 35 |
| Investing Activities | -53 | -91 | -39 | -24 | -49 | 1 | -12 | -43 | -42 | -18 | -18 |
| Financing Activities | -130 | -85 | -86 | -89 | -62 | -165 | -94 | -64 | -49 | -45 | -23 |
| Net Cash Flow | 8 | -9 | 4 | 0 | 5 | 4 | -5 | 0 | -1 | 5 | -6 |